The Employees' State Insurance Corporation (ESIC) on August 03, 2026, has issued a communication providing information on firms and products that have expressed willingness to continue drug supply under the extended period of DG-ESIC Rate Contracts (RC) 154, 155, 156, 157, and 158. This communication references ESIC Headquarters web upload no. 25580/2029, dated June 4, 2026.
The notice is issued in continuation of an earlier order — No. U-25/12/Exemption under Public Procurement (MII) Order/2022-Med.V (E-101005) — also dated June 4, 2026, which pertained to exemptions under the Public Procurement (Make in India) Order. The enclosed details list the specific firms and their corresponding products that have confirmed their willingness to supply drugs during the extension period of the referenced rate contracts.
The communication is circulated for information and necessary action by the concerned recipients, with the detailed list of willing firms/products enclosed as an attachment to the original notice.
[Notification No. U-25/12/Exemption under Public Procurement (MII) Order/2022-Med.V (E101005)/270]
